MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines.

J Ovarian Res · 2011 · PMC3205057 · PMID 21939554

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Even though difference in the levels of these 11 miRNAs between two cell lines is moderate but could be highly significant to change the sensitivity of ovarian cancer to cis-platin.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.